Skip to content

InfuSystem Holdings INFU Operating Lease Liability Payments - 2027 (Lessee)

Operating Lease Liability Payments - 2027 (Lessee) at other companies

Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
UFP Technologies logo
UFP TechnologiesUFPT
ICU Medical logo
ICU MedicalICUI
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$33.7M-3.0%
Gross profit$19.7M+2.7%
Operating income$1.6M+157%
Net income$1.0M+481%
EPS (diluted)$0.05+600%

Balance sheet

See full
Cash & equivalents$2.1M+39.8%
Total debt$24.1M-30.4%
Total equity$58.7M+6.5%
Total assets$98.7M-5.4%

Cash flow

See full
Operating cash flow$970.0K-45.5%
CapEx$157.0K+19.8%
Free cash flow$813.0K-50.7%

Valuation

See full
Market cap$205.05M+51.3%
Enterprise value$227.04M+36.2%
P/E25.9×-0.8×
P/S1.4×+0.5×

Profitability

See full
Gross margin56.7%+3.6pp
Operating margin9.1%+3.0pp
Net margin5.6%+3.2pp
FCF margin16.2%+1.0pp

Returns & leverage

See full
Return on equity13.9%+8.0pp
Debt / equity0.4×-0.2×
Current ratio2.1×-0.1×

Where this comes from

Reported directly by InfuSystem Holdings in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree.

The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InfuSystem Holdings's operating lease liability payments - 2027 (lessee).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InfuSystem Holdings's operating lease liability payments - 2027 (lessee)?
InfuSystem Holdings (INFU) reported operating lease liability payments - 2027 (lessee) of $1.4M in Q1 2026.
How has InfuSystem Holdings's operating lease liability payments - 2027 (lessee) changed year-over-year?
InfuSystem Holdings's operating lease liability payments - 2027 (lessee) decreased by 7.2% year-over-year, from $1.5M to $1.4M.